These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 203872)

  • 1. Pathological changes in chickens inoculated with reticuloendotheliosis-virus-contaminated Marek's disease vaccine.
    Taniguchi T; Yuasa N; Sato S; Horiuchi T
    Natl Inst Anim Health Q (Tokyo); 1977; 17(4):141-50. PubMed ID: 203872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a reticuloendotheliosis virus from chickens inoculated with Marek's disease vaccine.
    Yuasa N; Yoshida I; Taniguchi T
    Natl Inst Anim Health Q (Tokyo); 1976; 16(4):141-51. PubMed ID: 189220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inoculation experiment of Marek's disease vaccine contaminated with a reticuloendotheliosis virus.
    Kawamura H; Wakabayashi T; Yamaguchi S; Taniguchi T; Takayanagi N
    Natl Inst Anim Health Q (Tokyo); 1976; 16(4):135-40. PubMed ID: 189219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection studies on a reticuloendotheliosis virus contaminant of a commercial Marek's disease vaccine.
    Bagust TJ; Grimes TM; Dennett DP
    Aust Vet J; 1979 Apr; 55(4):153-7. PubMed ID: 223539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus.
    Calnek BW; Carlisle JC; Fabricant J; Murthy KK; Schat KA
    Am J Vet Res; 1979 Apr; 40(4):541-8. PubMed ID: 229747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Marek's disease.
    Payne LN; Frazier JA; Powell PC
    Int Rev Exp Pathol; 1976; 16():59-154. PubMed ID: 182652
    [No Abstract]   [Full Text] [Related]  

  • 7. Marek's disease in turkeys: lack of protection by vaccination.
    Elmubarak AK; Sharma JM; Witter RL; Sanger VL
    Am J Vet Res; 1982 Apr; 43(4):740-2. PubMed ID: 6280536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common occurrence of Gallid herpesvirus-2 with reticuloendotheliosis virus in chickens caused by possible contamination of vaccine stocks.
    Woźniakowski G; Mamczur A; Samorek-Salamonowicz E
    J Appl Microbiol; 2015 Apr; 118(4):803-8. PubMed ID: 25641090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on Marek's disease. II. Pathogenesis.
    Payne LN; Biggs PM
    J Natl Cancer Inst; 1967 Aug; 39(2):281-302. PubMed ID: 18623945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An outbreak in three-yellow chickens with clinical tumors of high mortality caused by the coinfection of reticuloendotheliosis virus and Marek's disease virus: a speculated reticuloendotheliosis virus contamination plays an important role in the case.
    Shi M; Li M; Wang P; Wang W; Li H; Gao Y; Lin L; Huang T; Wei P
    Poult Sci; 2021 Jan; 100(1):19-25. PubMed ID: 33357681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility to Marek's disease virus of local chickens in Taiwan.
    Lin JA; Lee TS
    Avian Dis; 1996; 40(3):576-81. PubMed ID: 8883787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological aspects of lymphoid organs in chickens with Marek's disease.
    Simu G; Ciobanu H; Ciobanu-Bîlc A
    Morphol Embryol (Bucur); 1980; 26(4):345-7. PubMed ID: 6450886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
    Karpathy RC; Firth GA; Tannock GA
    Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Marek's disease: a review.
    Purchase HG
    Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enhanced pathenogicity of chicken anemia agent (CAA) in dual infections with Marek's disease virus (MDV), infectious bursal disease virus (IBDV) or reticuloendotheliosis virus (REV)].
    von Bülow V; Rudolph R; Fuchs B
    Zentralbl Veterinarmed B; 1986 Mar; 33(2):93-116. PubMed ID: 3014789
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine.
    Lee LF; Witter RL
    Avian Dis; 1991; 35(3):452-9. PubMed ID: 1659363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
    Calnek BW; Harris RW; Buscaglia C; Schat KA; Lucio B
    Avian Dis; 1998; 42(1):124-32. PubMed ID: 9533089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a bivalent vaccine against Marek's disease.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Mar; 42(2):145-9. PubMed ID: 3035660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.